PFIZER INC Quarterly Depreciation, Depletion and Amortization in USD from Q1 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Pfizer Inc quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2010 to Q1 2024.
  • Pfizer Inc Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $1.74B, a 16.7% increase year-over-year.
  • Pfizer Inc annual Depreciation, Depletion and Amortization for 2023 was $6.29B, a 24.2% increase from 2022.
  • Pfizer Inc annual Depreciation, Depletion and Amortization for 2022 was $5.06B, a 2.45% decline from 2021.
  • Pfizer Inc annual Depreciation, Depletion and Amortization for 2021 was $5.19B, a 10.9% increase from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.74B +$249M +16.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q1 2023 $1.49B Jan 1, 2023 Apr 2, 2023 10-Q 2024-05-08
Q1 2013 $1.77B -$447M -20.1% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-10
Q1 2012 $2.22B +$117M +5.56% Jan 1, 2012 Apr 1, 2012 10-Q 2013-05-10
Q1 2011 $2.1B +$53M +2.58% Jan 1, 2011 Apr 3, 2011 10-Q 2012-05-10
Q1 2010 $2.05B Jan 1, 2010 Apr 4, 2010 10-Q 2011-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.